Sight Sciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -676.5% | – | – | – | – | – | – | – | |
| – | +18.8% | +1.1% | -3.1% | +31.2% | -27.9% | -15.3% | -16.1% | -16.0% | +2.9% | -4.6% | -8.7% | – | |
| – | -10.3% | +30.2% | -4.2% | -0.2% | -8.4% | +7.5% | -9.5% | -37.0% | +5.3% | +11.9% | +3.9% | – | |
| – | – | +167.6% | -487.3% | – | +172.5% | -157.8% | – | -7,126.5% | – | – | -266.2% | – | |
| – | -13.2% | -55.7% | -31.6% | -36.3% | +168.6% | -100.0% | – | -19.0% | -8.2% | -61.5% | -68.3% | – | |
| – | -13.2% | -55.7% | -31.6% | -36.3% | +168.6% | – | – | -19.0% | – | -138.5% | -68.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +218.6% | -350.5% | – | -136.7% | – | -99.7% | +2,931.3% | -94.8% | +4,960.0% | -93.0% | +438.6% | – | |
| – | – | – | – | – | +363.3% | -746.3% | – | – | – | – | – | – | |
| – | – | – | – | – | -755.0% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.